Physician profile
Denise E Lester
NPI 1699887034
$701.17
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $80.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $241.44 | 2019-2020 | |
| Abbvie INC. | $102.70 | 2019-2020 | |
| Amgen INC. | $99.99 | 2019 | |
| Therapeuticsmd, INC. | $59.70 | 2019 | |
| Allergan, INC. | $44.14 | 2019 | |
| Exeltis, USA INC. | $44.14 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $30.66 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.65 | 2019 | |
| Duchesnay USA Incorporated | $16.10 | 2019 | |
| Coopersurgical, INC. | $15.54 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.20 | 2019 | |
| Avion Pharmaceuticals | $13.91 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Lester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.